Credit Suisse AG, London Branch Share Price

Certificat

DE000CS8S473

Market Closed - Deutsche Boerse AG 12:14:34 21/06/2024 BST
1,005 EUR -0.03% Intraday chart for Credit Suisse AG, London Branch
Current month-1.69%
1 month+1.40%
Date Price Change
21/06/24 1,005 -0.03%
20/06/24 1,005 -0.33%
19/06/24 1,009 -1.05%
18/06/24 1,019 -0.53%

Delayed Quote Deutsche Boerse AG

Last update June 21, 2024 at 12:14 pm

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Credit Suisse
WKN CS8S47
ISINDE000CS8S473
Date issued 26/01/2022
Strike 79.87 CHF
Maturity 21/03/2028 (1362 Days)
Parity 0.08 : 1
Emission price 1,000
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 1,046
Lowest since issue 569.9

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107 USD
Average target price
110.3 USD
Spread / Average Target
+3.04%
Consensus